Amplitude Surgical reported FY 1Q20 revenue of €20.8 million (USD $23.4 million), +6.7% vs. FY 1Q19.
Amplitude Surgical’s growth was driven by the strength of subsidiaries in markets outside of France (+15.9% vs. prior year), with sales in the U.S. nearly doubling compared to FY 1Q19
International subsidiary growth was partially offset by a downturn in sales from international distributors (-4.3% vs. prior year)
The company’s Novastep foot and ankle product line growth was driven by sales in the U.S.
ORTHOWORLD projects Amplitude Surgical full calendar year 2019 orthopedic revenue of $121.3 million, +5.1% vs. 2018
Revenue Data
All revenue data is provided in USD millions unless otherwise noted. Sales and growth rates are estimated on an as-reported basis.
Segment Sales
FY 1Q20
FY 1Q19
$ Chg
% Chg
Joint Replacement
$22.5
$21.1
$1.4
6.8%
Knees
$11.9
$11.3
$0.6
5.2%
Hips
$8.4
$8.2
$0.2
2.8%
Extremities
$2.2
$1.6
$0.6
39.6%
Sports Medicine
$0.7
$0.7
$0.0
1.4%
Orthobiologics
$0.2
$0.2
$0.0
6.1%
Total
$23.4
$21.9
$1.5
6.7%
Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email.
Amplitude Surgical reported FY 1Q20 revenue of €20.8 million (USD $23.4 million), +6.7% vs. FY 1Q19.
Amplitude Surgical’s growth was driven by the strength of subsidiaries in markets outside of France (+15.9% vs. prior year), with sales in the U.S. nearly doubling compared to FY 1Q19 International subsidiary growth was partially...
Amplitude Surgical reported FY 1Q20 revenue of €20.8 million (USD $23.4 million), +6.7% vs. FY 1Q19.
Amplitude Surgical’s growth was driven by the strength of subsidiaries in markets outside of France (+15.9% vs. prior year), with sales in the U.S. nearly doubling compared to FY 1Q19
International subsidiary growth was partially offset by a downturn in sales from international distributors (-4.3% vs. prior year)
The company’s Novastep foot and ankle product line growth was driven by sales in the U.S.
ORTHOWORLD projects Amplitude Surgical full calendar year 2019 orthopedic revenue of $121.3 million, +5.1% vs. 2018
Revenue Data
All revenue data is provided in USD millions unless otherwise noted. Sales and growth rates are estimated on an as-reported basis.
Segment Sales
FY 1Q20
FY 1Q19
$ Chg
% Chg
Joint Replacement
$22.5
$21.1
$1.4
6.8%
Knees
$11.9
$11.3
$0.6
5.2%
Hips
$8.4
$8.2
$0.2
2.8%
Extremities
$2.2
$1.6
$0.6
39.6%
Sports Medicine
$0.7
$0.7
$0.0
1.4%
Orthobiologics
$0.2
$0.2
$0.0
6.1%
Total
$23.4
$21.9
$1.5
6.7%
Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
